Walgreens reaches $683 mln opioid settlement with Florida
By Dietrich Knauth
May 5 (Reuters) - Walgreens Boots Alliance WBA.O said on
Thursday it has reached a $683 million settlement with Florida
to resolve claims that the pharmacy chain exacerbated an opioid
epidemic in the state.
The settlement includes $620 million to be paid to Florida
over 18 years, plus $63 million for legal fees.
It ends a trial that began on April 11, after Walgreens
decided not to join a combined $878 million settlement with four
other healthcare companies.
(Reporting by Dietrich Knauth; Editing by Bill Berkrot and
Chizu Nomiyama)
((Dietrich.Knauth@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes